🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Lapatinib and everolimus may stop the growth of cancer cells by ...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
2006-09
Trial ID
NCT00352443
Treatments Being Tested
Primary cutaneous squamous cell carcinomas (SCCs) are epithelial carcinomas...
Status
Terminated
Location
University Hospital Zurich, Division of Dermatology
Start Date
2012-06
Trial ID
NCT01666431
Treatments Being Tested
This phase I trial studies the side effects and best dose of entinostat whe...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2012-01-10
Trial ID
NCT01434303
Treatments Being Tested
The primary objective: -To assess the efficacy of TCH and TCHL in neo-adju...
Status
Completed
Location
St James's Hospital
Start Date
2010-10
Trial ID
NCT01485926
Treatments Being Tested
Evaluating the Efficacy of Lapatinib in Combination With Chemotherapy in Pa...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2015-01-09
Trial ID
NCT02362958
Treatments Being Tested
Breast cancer is the most common malignancy in the U.S. Targeted therapies ...
Status
Active Not Recruiting
Location
University of Alabama - Birmingham
Start Date
2011-10
Trial ID
NCT00999804
Treatments Being Tested
By doing this study, researchers hope to learn the effectiveness of the com...
Status
Unknown
Location
University of Kansas Medical Centner
Start Date
2011-02
Trial ID
NCT01283789
Treatments Being Tested
This is a randomized, parallel-arm, open-label, multi-centre, Phase II stud...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11-25
Trial ID
NCT01013740
Treatments Being Tested
This study is for patients with ErbB2 overexpressing breast cancer that has...
Status
Terminated
Location
GSK Investigational Site
Start Date
2007-05
Trial ID
NCT00437073
Treatments Being Tested
Despite these initial positive signals in recent statistics, breast cancer ...
Status
Completed
Location
Dr. Guillermo Lerzo
Start Date
2009-11
Trial ID
NCT01050322
Treatments Being Tested